Tirzepatide is a synthetic peptide designed to mimic the biological activity of both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. In in vitro environments, it is often investigated for its dual receptor activity and potential implications in studies involving energy balance, glucose metabolism, and receptor signaling cascades. Its unique structure allows researchers to explore synergistic effects in metabolic research.